Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL)
Clinical trial NCT03298893 · COMPLETED
Trial details
- NCT number
- NCT03298893
- Sponsor
- Institut Curie
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2020-10-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.